Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality throughout the world. In the paper the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendation are presented. The GOLD report points out that tobacco smoking is a major cause of COPD. The author describes clinical and spirometric characteristics of COPD and a pharmacological approach to the treatment of that disease. According to the GOLD report, patients with mild COPD should be treated with short-acting inhaled ?2-agonists and/or anticholinergic drugs as needed. Long-acting ?2-agonists (salmeterol, formoterol) and long-acting anticholinergic (tiotropium bromide) drugs are recommended for the treatment of moderate and severe COPD, while in severe COPD cases this therapy should be supplemented with treatment with inhaled glucocorticosteroids.
keywords: przewlekła oburacyjna choroba płuc, ?2-agoniści, wziewne glikokortykosteroidy, chronic obstructive pulmonary disease, β2-agonists, inhaled glucocorticosteroids
pages: from 188 to 194
|estimated time of download (129 kB)|